Our promise to you is to resolve: resolve your challenges with exceptional solutions; resolve your scientific needs through our deep knowledge and agility; resolve your projects with an open mindset and seamless communication.
We believe that uncompromising professional and scientific integrity yields trustful, genuine relationships – and we understand that this is vital to enduring collaborations.
Our global bioanalytics division has an extensive track record across therapeutic modalities and biological matrices, including conventional small molecules, peptides, large proteins and antibodies, antibody-drug conjugates, and oligonucleotides.
Our vast expertise, from next-generation biologics to cell and gene therapy, allows us to find solutions to the most challenging bioanalytical methods and assays.
Our dedicated analytical sciences division has over two decades of experience solving the most complex challenges in testing raw materials, formulated products, packaging and medical devices for trace impurities, contamination, degradation and quality control. Our analytical and materials science solutions support CMC (Chemistry Manufacturing and Control) analytical testing and GMP (Good Manufacturing Practice) standards.
Collaborating on all therapeutic modalities, Resolian fuses expertise from Alliance Pharma and Drug Development Solutions to provide world-class scientific solutions.
We are an ever-expanding global team of experts, resolute in our goal to offer an accessible, enhanced customer experience through a personalized approach and proactive management.
Choose a location
Your experts in:
+ Over 25 years of experience in Europe
Your specialist in:
+ Over 20 years of experience in Europe
Your experts in:
+ Over 15 years of experience in the US
Your experts in:
Specialists in Australia
Learn MoreThis site contains links to the following affiliate entities: Alliance Pharma Inc. (doing business as Resolian), Drug Development Solutions Ltd. (trading as Resolian). Resolian is not currently trademarked in any geography.